Investigating the Relationships Between Body Composition, Peripheral Muscle Strength, and Cough Force in Healthy Young Adults

NCT ID: NCT07311837

Last Updated: 2025-12-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

46 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-02-15

Study Completion Date

2026-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Introduction: Body mass index (BMI) is a key parameter used for obesity classification and the evaluation and monitoring of individuals' health status. Obesity, described by the World Health Organization as a major global epidemic, remains one of the most significant preventable and manageable conditions contributing to increased risks of cardiovascular and metabolic diseases. In addition to BMI, anthropometric measurements such as the waist-to-hip ratio are crucial indicators for risk assessment. While numerous studies in the literature have addressed the detrimental effects of obesity on respiratory functions, no study has specifically examined the relationship between cough strength-a vital respiratory parameter that reflects expiratory muscle strength- and body composition, waist-to-hip ratio, and peripheral muscle strength. Furthermore, although several studies have investigated the association between grip strength-a recognized indicator of peripheral muscle function in healthy individuals-and cough strength, no research to date has explored the relationship between pinch grip strength and cough strength.

Objective: This study aims to investigate the relationships among body composition, waist-to-hip ratio, peripheral muscle strength, and cough strength in healthy young adults.

Methods: This study was designed as a cross-sectional analysis. After providing detailed information about the study to potential participants, written informed consent will be obtained in duplicate from those who agree to participate. Following the completion of a general assessment form that captures demographic characteristics, each participant's height will be measured using a measuring tape. Body composition parameters-including body weight, BMI, body fat percentage, total body water percentage, muscle mass, basal metabolic rate, and metabolic age-will be assessed using a bioelectrical impedance analysis device (Tanita) available at our faculty.

Waist and hip circumferences will be measured and used to calculate the waist-to-hip ratio for each participant. Peripheral muscle strength will be assessed using a hydraulic hand dynamometer and a pinch meter, while cough strength will be evaluated using a peak cough expiratory flow meter (PEF meter). All measurements will be repeated three times, with the best result recorded for analysis. Results: Statistical analysis will be performed using IBM SPSS Statistics version 30 (SPSS Inc., Chicago, IL, USA). Normality of continuous variables will be assessed through normality tests, coefficient of variation, and graphical representations (e.g., histograms, detrended plots). Descriptive statistics will be presented as mean ± standard deviation for normally distributed variables, and as median and interquartile range for non-normally distributed variables. Categorical variables will be expressed as percentages (%). Pearson correlation analysis will be used for normally distributed variables, and Spearman correlation analysis for non-normally distributed ones. The appropriate correlation coefficients and p-values will be reported. A p-value of \<0.05 will be considered statistically significant.

Discussion: Interpretation will be based on the results of the statistical analyses.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Body mass index (BMI) is an important parameter used to assess and monitor the health status of individuals by classifying obesity. Obesity, defined as a major epidemic by the World Health Organization, is the most important preventable and controllable problem that increases the risk of cardiovascular and metabolic diseases. It is estimated that more than 1 billion adults worldwide will be obese by 2030 (1,2). The COVID-19 pandemic and the increasing dependence on technology are increasing the sedentary population and changing dietary habits, thereby increasing obesity rates (3,4). In addition to BMI, the waist-to-hip ratio, an anthropometric measurement, is also an important parameter in determining risk. In individuals with abdominal fat or atrophy in large muscle groups, waist circumference may be larger than hip circumference. This results in a high waist-to-hip ratio (5). Many studies conducted during the COVID-19 pandemic have reported higher COVID-19-related mortality rates in countries with obese or overweight individuals. This situation has revealed that overweight and obese individuals are a highly vulnerable group to epidemic diseases (1). Furthermore, the literature has addressed the mechanical effects of obesity on the respiratory system, and its relationship with asthma and other respiratory diseases has been discussed (6,7). It has been reported that all respiratory function parameters are negatively affected in obese individuals with a high BMI, and other physiological mechanisms affecting respiratory mechanics are not yet understood (8-11). It is known that the abdominal muscles, which are active during forced expiration, are associated with cough force, a forced expiratory maneuver. It is thought that cough force will decrease with increasing BMI and obesity, along with weakening of the abdominal wall muscles and abdominal fat accumulation. While there are studies in the literature mentioning the negative effects of obesity on respiratory function and reporting that grip strength is related to cough force in healthy individuals (12), no studies have been found on the relationship between cough force, an important respiratory parameter that reflects expiratory muscle strength, and body composition, waist/hip ratio, and peripheral muscle strength. Our study will be the first and pioneering study to investigate the relationships between body composition, waist-to-hip ratio, peripheral muscle strength, and cough strength in healthy young adults. Furthermore, the fact that body composition will be measured using the body analysis system, the gold standard method, increases the originality of our study. One of the unique merits of our study is that it will reveal the relationships between body composition, waist-to-hip ratio, peripheral muscle strength, and cough strength in individuals known to be healthy and free of chronic diseases.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Young Adults

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Body composition Waist-to-hip ratio Peripheral muscle strength Peak expiratory flow Cough strength

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Young Adults

Healthy individuals between the ages of 18 and 30 who volunteer to participate in the study will be included in the study.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals between the ages of 18-30 who volunteered to participate in the study

Exclusion Criteria

* Individuals who have a serious orthopedic, neurological or systemic disease that would prevent participation in the study and who do not volunteer to participate in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nigde Omer Halisdemir University

OTHER

Sponsor Role lead

The Scientific and Technological Research Council of Turkey

OTHER

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nazire Nur YILDIZ

P.T., Ph.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nazire Nur YILDIZ, Ph.D.

Role: STUDY_CHAIR

Nigde Omer Halisdemir University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nigde Omer Halisdemir University, Faculty of Bor Health Sciences

Niğde, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nazire Nur YILDIZ, Ph.D.

Role: CONTACT

Phone: +905444184376

Email: [email protected]

Nurcan AYTEKİN, Student

Role: CONTACT

Phone: +905386941695

Email: [email protected]

References

Explore related publications, articles, or registry entries linked to this study.

Mafort TT, Rufino R, Costa CH, Lopes AJ. Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function. Multidiscip Respir Med. 2016 Jul 12;11:28. doi: 10.1186/s40248-016-0066-z. eCollection 2016.

Reference Type BACKGROUND
PMID: 27408717 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025/09-10-TUBITAK 2209-A

Identifier Type: -

Identifier Source: org_study_id